PAPER Zhu M, Allard JS, Zhang Y, Perez E, Spangler EL, Becker KG, Rapp PR
SEARCH RESULTS
331254 RESULTS
PAPER Iacono D, Resnick SM, O'Brien R, Zonderman AB, An Y, Pletnikova O, Rudow G, Crain B, Troncoso JC
Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.
J Neuropathol Exp Neurol. 2014 Apr;73(4):295-304. PubMed: 24607960PAPER Lau P, Sala Frigerio C, De Strooper B
Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: The need of larger datasets.
Ageing Res Rev. 2014 Sep;17C:43-53. Epub 2014 Mar 4 PubMed: 24607832PAPER Marciani DJ
New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies.
Drug Discov Today. 2014 Jul;19(7):912-20. Epub 2014 Mar 6 PubMed: 24607730PAPER Egea J, Romero A, Parada E, León R, Dal-Cim T, López MG
Neuroprotective effect of dimebon against ischemic neuronal damage.
Neuroscience. 2014 May 16;267:11-21. Epub 2014 Mar 4 PubMed: 24607349PAPER Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, Pankratz S, Sando SB, Aasly JO, Barcikowska M, Siuda J, Wszolek ZK, Ross OA, Carrasquillo M, Dickson DW, Graff-Radford N, Petersen RC, Ertekin-Taner N, Morgan K, Bu G, Younkin SG
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.
Mol Neurodegener. 2014 Mar 10;9:11. PubMed: 24607147PAPER Quinn C, Anderson D, Toms G, Whitaker R, Edwards RT, Jones C, Clare L
Self-management in early-stage dementia: a pilot randomised controlled trial of the efficacy and cost-effectiveness of a self-management group intervention (the SMART study).
Trials. 2014 Mar 8;15:74. PubMed: 24606601PAPER Segatto M, Leboffe L, Trapani L, Pallottini V
Cholesterol homeostasis failure in the brain: implications for synaptic dysfunction and cognitive decline.
Curr Med Chem. 2014;21(24):2788-802. PubMed: 24606521PAPER Nguyen PH, Li MS, Derreumaux P
Amyloid oligomer structure characterization from simulations: a general method.
J Chem Phys. 2014 Mar 7;140(9):094105. PubMed: 24606351PAPER Musunuri S, Wetterhall M, Ingelsson M, Lannfelt L, Artemenko K, Bergquist J, Kultima K, Shevchenko G
Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometry.
J Proteome Res. 2014 Apr 4;13(4):2056-68. Epub 2014 Mar 19 PubMed: 24606058PAPER Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.
J Intern Med. 2014 Mar;275(3):304-16. PubMed: 24605810PAPER Lannfelt L, Relkin NR, Siemers ER
Amyloid-ß-directed immunotherapy for Alzheimer's disease.
J Intern Med. 2014 Mar;275(3):284-95. PubMed: 24605809PAPER Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.
J Intern Med. 2014 Mar;275(3):251-83. PubMed: 24605808PAPER Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M
Advances in the prevention of Alzheimer's disease and dementia.
J Intern Med. 2014 Mar;275(3):229-50. PubMed: 24605807PAPER Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L
Mild cognitive impairment: a concept in evolution.
J Intern Med. 2014 Mar;275(3):214-28. PubMed: 24605806Current Filters
No filters selected